Author： Nisoli E. Carruba M.O.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.26, Iss.14, 2003-01, pp. : 1027-1048
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Benefit-Risk Assessment of Antileukotrienes in the Management of Asthma
Drug Safety, Vol. 26, Iss. 7, 2003-01 ,pp. :
Access to resources
Recommend
Benefit-Risk Assessment of Ropivacaine in the Management of Postoperative Pain
By Wolfgang Zink Bernhard M. Graf
Drug Safety, Vol. 27, Iss. 14, 2004-01 ,pp. :
Sibutramine and the management of obesity
By Poston Walker S Carlos Foreyt John P
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. :
Cardiovascular Risk-Benefit Profile of Sibutramine
By Scheen A.J.
American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. :
Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer
Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. :